Endocrinology of the Aging Prostate: Current Concepts
February 2021
in “
Frontiers in Endocrinology
”
estrogen insulin-like growth factor IGF thyroid hormones estrogen receptor alpha ERbeta IGF1 benign prostatic hyperplasia BPH triiodothyronine T3 metabolic syndrome hyperinsulinemia dyslipidemia androgen-targeted therapies castration resistance obesity metformin polycystic ovary syndrome PCOS androgenetic alopecia
Studysummary This review explores the potential impact of hormonal changes during aging on benign prostate hyperplasia-related urinary symptoms and metabolic syndrome, highlighting the hypothesis of a male PCOS-equivalent but reports no new clinical results.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on frontiersin.org →